nodes	percent_of_prediction	percent_of_DWPC	metapath
Butorphanol—Gait disturbance—Carmustine—lymphatic system cancer	0.00784	0.00784	CcSEcCtD
Butorphanol—Coordination abnormal—Carmustine—lymphatic system cancer	0.0078	0.0078	CcSEcCtD
Butorphanol—Dysphagia—Fludarabine—lymphatic system cancer	0.0075	0.0075	CcSEcCtD
Butorphanol—Gait disturbance—Vincristine—lymphatic system cancer	0.00749	0.00749	CcSEcCtD
Butorphanol—Respiratory failure—Vincristine—lymphatic system cancer	0.00744	0.00744	CcSEcCtD
Butorphanol—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.00739	0.00739	CcSEcCtD
Butorphanol—Sweating—Teniposide—lymphatic system cancer	0.0073	0.0073	CcSEcCtD
Butorphanol—Vertigo—Mechlorethamine—lymphatic system cancer	0.00725	0.00725	CcSEcCtD
Butorphanol—Bronchitis—Fludarabine—lymphatic system cancer	0.00722	0.00722	CcSEcCtD
Butorphanol—Upper respiratory tract infection—Fludarabine—lymphatic system cancer	0.00697	0.00697	CcSEcCtD
Butorphanol—Injury—Bleomycin—lymphatic system cancer	0.00693	0.00693	CcSEcCtD
Butorphanol—Mental disability—Carmustine—lymphatic system cancer	0.00664	0.00664	CcSEcCtD
Butorphanol—Epistaxis—Fludarabine—lymphatic system cancer	0.00631	0.00631	CcSEcCtD
Butorphanol—Anorexia—Mechlorethamine—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Butorphanol—Sinusitis—Fludarabine—lymphatic system cancer	0.00628	0.00628	CcSEcCtD
Butorphanol—Eye pain—Carmustine—lymphatic system cancer	0.00616	0.00616	CcSEcCtD
Butorphanol—Chills—Teniposide—lymphatic system cancer	0.00613	0.00613	CcSEcCtD
Butorphanol—Arrhythmia—Teniposide—lymphatic system cancer	0.00611	0.00611	CcSEcCtD
Butorphanol—Injury—Carmustine—lymphatic system cancer	0.00605	0.00605	CcSEcCtD
Butorphanol—Pharyngitis—Fludarabine—lymphatic system cancer	0.00596	0.00596	CcSEcCtD
Butorphanol—Deafness—Vincristine—lymphatic system cancer	0.00593	0.00593	CcSEcCtD
Butorphanol—Visual impairment—Fludarabine—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Butorphanol—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Butorphanol—Hypoxia—Methotrexate—lymphatic system cancer	0.00558	0.00558	CcSEcCtD
Butorphanol—Diplopia—Carmustine—lymphatic system cancer	0.00556	0.00556	CcSEcCtD
Butorphanol—Agitation—Teniposide—lymphatic system cancer	0.00547	0.00547	CcSEcCtD
Butorphanol—Chills—Fludarabine—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Butorphanol—Arrhythmia—Fludarabine—lymphatic system cancer	0.00537	0.00537	CcSEcCtD
Butorphanol—Pain in extremity—Vincristine—lymphatic system cancer	0.0053	0.0053	CcSEcCtD
Butorphanol—Ataxia—Carmustine—lymphatic system cancer	0.00523	0.00523	CcSEcCtD
Butorphanol—Hypertension—Teniposide—lymphatic system cancer	0.00514	0.00514	CcSEcCtD
Butorphanol—Chest pain—Teniposide—lymphatic system cancer	0.00507	0.00507	CcSEcCtD
Butorphanol—Ataxia—Vincristine—lymphatic system cancer	0.00499	0.00499	CcSEcCtD
Butorphanol—Confusional state—Teniposide—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Butorphanol—Oedema—Teniposide—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Butorphanol—Agitation—Fludarabine—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Butorphanol—Dysphagia—Carmustine—lymphatic system cancer	0.0048	0.0048	CcSEcCtD
Butorphanol—Stupor—Methotrexate—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Butorphanol—Tachycardia—Teniposide—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Butorphanol—Abdominal pain upper—Mitoxantrone—lymphatic system cancer	0.00472	0.00472	CcSEcCtD
Butorphanol—Hyperhidrosis—Teniposide—lymphatic system cancer	0.00469	0.00469	CcSEcCtD
Butorphanol—Pruritus—Mechlorethamine—lymphatic system cancer	0.00466	0.00466	CcSEcCtD
Butorphanol—Anorexia—Teniposide—lymphatic system cancer	0.00463	0.00463	CcSEcCtD
Butorphanol—Cough—Fludarabine—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Butorphanol—Hypotension—Teniposide—lymphatic system cancer	0.00454	0.00454	CcSEcCtD
Butorphanol—Convulsion—Fludarabine—lymphatic system cancer	0.00453	0.00453	CcSEcCtD
Butorphanol—Dyspnoea—Teniposide—lymphatic system cancer	0.00433	0.00433	CcSEcCtD
Butorphanol—Petechiae—Methotrexate—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Butorphanol—Confusional state—Fludarabine—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Butorphanol—Depression—Carmustine—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Butorphanol—Oedema—Fludarabine—lymphatic system cancer	0.00427	0.00427	CcSEcCtD
Butorphanol—Decreased appetite—Teniposide—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Butorphanol—Vomiting—Mechlorethamine—lymphatic system cancer	0.00419	0.00419	CcSEcCtD
Butorphanol—Apnoea—Methotrexate—lymphatic system cancer	0.00418	0.00418	CcSEcCtD
Butorphanol—Rash—Mechlorethamine—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Butorphanol—Upper respiratory tract infection—Mitoxantrone—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Butorphanol—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Butorphanol—Hyperhidrosis—Fludarabine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Butorphanol—Depression—Vincristine—lymphatic system cancer	0.00408	0.00408	CcSEcCtD
Butorphanol—Anorexia—Fludarabine—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Butorphanol—Feeling abnormal—Teniposide—lymphatic system cancer	0.004	0.004	CcSEcCtD
Butorphanol—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Butorphanol—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Butorphanol—Chills—Bleomycin—lymphatic system cancer	0.00395	0.00395	CcSEcCtD
Butorphanol—Sweating—Vincristine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Butorphanol—Nausea—Mechlorethamine—lymphatic system cancer	0.00391	0.00391	CcSEcCtD
Butorphanol—Urticaria—Teniposide—lymphatic system cancer	0.00386	0.00386	CcSEcCtD
Butorphanol—Abdominal pain—Teniposide—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Butorphanol—Body temperature increased—Teniposide—lymphatic system cancer	0.00384	0.00384	CcSEcCtD
Butorphanol—Erythema—Bleomycin—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Butorphanol—Paraesthesia—Fludarabine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Butorphanol—Hallucination—Carmustine—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Butorphanol—Sweating—Mitoxantrone—lymphatic system cancer	0.00382	0.00382	CcSEcCtD
Butorphanol—Dyspnoea—Fludarabine—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Butorphanol—Dysarthria—Methotrexate—lymphatic system cancer	0.00375	0.00375	CcSEcCtD
Butorphanol—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00374	0.00374	CcSEcCtD
Butorphanol—Decreased appetite—Fludarabine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Butorphanol—Visual impairment—Carmustine—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Butorphanol—Hallucination—Vincristine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Butorphanol—Constipation—Fludarabine—lymphatic system cancer	0.00365	0.00365	CcSEcCtD
Butorphanol—Respiratory failure—Methotrexate—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Butorphanol—Eye disorder—Carmustine—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Butorphanol—Rhinitis—Mitoxantrone—lymphatic system cancer	0.00358	0.00358	CcSEcCtD
Butorphanol—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Butorphanol—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00352	0.00352	CcSEcCtD
Butorphanol—Asthenia—Teniposide—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Butorphanol—Pruritus—Teniposide—lymphatic system cancer	0.00344	0.00344	CcSEcCtD
Butorphanol—Arrhythmia—Carmustine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Butorphanol—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.00342	0.00342	CcSEcCtD
Butorphanol—Body temperature increased—Fludarabine—lymphatic system cancer	0.00337	0.00337	CcSEcCtD
Butorphanol—Erythema—Carmustine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Butorphanol—Cough—Bleomycin—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Butorphanol—Chest pain—Bleomycin—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Butorphanol—Back pain—Carmustine—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Butorphanol—Chills—Mitoxantrone—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Butorphanol—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Butorphanol—Confusional state—Bleomycin—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Butorphanol—Vision blurred—Carmustine—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Butorphanol—Tremor—Carmustine—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Butorphanol—Oedema—Bleomycin—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Butorphanol—Erythema—Mitoxantrone—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Butorphanol—Back pain—Vincristine—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Butorphanol—Vomiting—Teniposide—lymphatic system cancer	0.00309	0.00309	CcSEcCtD
Butorphanol—Agitation—Carmustine—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Butorphanol—Asthenia—Fludarabine—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Butorphanol—Rash—Teniposide—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Butorphanol—Dermatitis—Teniposide—lymphatic system cancer	0.00306	0.00306	CcSEcCtD
Butorphanol—Headache—Teniposide—lymphatic system cancer	0.00304	0.00304	CcSEcCtD
Butorphanol—Pruritus—Fludarabine—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Butorphanol—Back pain—Mitoxantrone—lymphatic system cancer	0.00301	0.00301	CcSEcCtD
Butorphanol—Anorexia—Bleomycin—lymphatic system cancer	0.00298	0.00298	CcSEcCtD
Butorphanol—Agitation—Vincristine—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Butorphanol—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Butorphanol—Hypotension—Bleomycin—lymphatic system cancer	0.00292	0.00292	CcSEcCtD
Butorphanol—Convulsion—Carmustine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Butorphanol—Hypertension—Carmustine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Butorphanol—Nausea—Teniposide—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Butorphanol—Vertigo—Vincristine—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Butorphanol—Chest pain—Carmustine—lymphatic system cancer	0.00285	0.00285	CcSEcCtD
Butorphanol—Anxiety—Carmustine—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Butorphanol—Paraesthesia—Bleomycin—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Butorphanol—Dyspnoea—Bleomycin—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Butorphanol—Convulsion—Vincristine—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Butorphanol—Hypertension—Vincristine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Butorphanol—Confusional state—Carmustine—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Butorphanol—Oedema—Carmustine—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Butorphanol—Decreased appetite—Bleomycin—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Butorphanol—Visual disturbance—Methotrexate—lymphatic system cancer	0.00272	0.00272	CcSEcCtD
Butorphanol—Cough—Mitoxantrone—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Butorphanol—Vomiting—Fludarabine—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Butorphanol—Convulsion—Mitoxantrone—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Butorphanol—Rash—Fludarabine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Butorphanol—Dermatitis—Fludarabine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Butorphanol—Hypertension—Mitoxantrone—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Butorphanol—Headache—Fludarabine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Butorphanol—Tachycardia—Carmustine—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Butorphanol—Chest pain—Mitoxantrone—lymphatic system cancer	0.00265	0.00265	CcSEcCtD
Butorphanol—Anxiety—Mitoxantrone—lymphatic system cancer	0.00264	0.00264	CcSEcCtD
Butorphanol—Lethargy—Methotrexate—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Butorphanol—Oedema—Vincristine—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Butorphanol—Anorexia—Carmustine—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Butorphanol—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Butorphanol—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Butorphanol—Confusional state—Mitoxantrone—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Butorphanol—Hypotension—Carmustine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Butorphanol—Oedema—Mitoxantrone—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Butorphanol—Nausea—Fludarabine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Butorphanol—Hyperhidrosis—Vincristine—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Butorphanol—Shock—Mitoxantrone—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Butorphanol—Urticaria—Bleomycin—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Butorphanol—Anorexia—Vincristine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Butorphanol—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Butorphanol—Body temperature increased—Bleomycin—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Butorphanol—Insomnia—Carmustine—lymphatic system cancer	0.00247	0.00247	CcSEcCtD
Butorphanol—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Butorphanol—Paraesthesia—Carmustine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Butorphanol—Hypotension—Vincristine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Butorphanol—Dyspnoea—Carmustine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Butorphanol—Somnolence—Carmustine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Butorphanol—Anorexia—Mitoxantrone—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Butorphanol—Ataxia—Methotrexate—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Butorphanol—Decreased appetite—Carmustine—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Butorphanol—Hypotension—Mitoxantrone—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Butorphanol—Insomnia—Vincristine—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Butorphanol—Paraesthesia—Vincristine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Butorphanol—Constipation—Carmustine—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Butorphanol—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00228	0.00228	CcSEcCtD
Butorphanol—Decreased appetite—Vincristine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Butorphanol—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Butorphanol—Somnolence—Mitoxantrone—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Butorphanol—Feeling abnormal—Carmustine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Butorphanol—Asthenia—Bleomycin—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Butorphanol—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Butorphanol—Constipation—Vincristine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Butorphanol—Pruritus—Bleomycin—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Butorphanol—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Butorphanol—Constipation—Mitoxantrone—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Butorphanol—Abdominal pain—Carmustine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Butorphanol—Body temperature increased—Carmustine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Butorphanol—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Butorphanol—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Butorphanol—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Butorphanol—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Butorphanol—Body temperature increased—Vincristine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Butorphanol—Abdominal pain—Vincristine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Butorphanol—Urticaria—Mitoxantrone—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Butorphanol—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Butorphanol—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Butorphanol—Vomiting—Bleomycin—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Butorphanol—Drowsiness—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Butorphanol—Depression—Methotrexate—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Butorphanol—Rash—Bleomycin—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Butorphanol—Dermatitis—Bleomycin—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Butorphanol—Asthenia—Carmustine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Butorphanol—Sweating—Methotrexate—lymphatic system cancer	0.0019	0.0019	CcSEcCtD
Butorphanol—Epistaxis—Methotrexate—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Butorphanol—Asthenia—Vincristine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Butorphanol—Nausea—Bleomycin—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Butorphanol—Asthenia—Mitoxantrone—lymphatic system cancer	0.00182	0.00182	CcSEcCtD
Butorphanol—Dizziness—Carmustine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Butorphanol—Pharyngitis—Methotrexate—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Butorphanol—Vomiting—Carmustine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Butorphanol—Dizziness—Vincristine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Butorphanol—Rash—Carmustine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Butorphanol—Dermatitis—Carmustine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Butorphanol—Visual impairment—Methotrexate—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Butorphanol—Headache—Carmustine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Butorphanol—Eye disorder—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Butorphanol—Tinnitus—Methotrexate—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Butorphanol—Vomiting—Vincristine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Butorphanol—Rash—Vincristine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Butorphanol—Dermatitis—Vincristine—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Butorphanol—Headache—Vincristine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Butorphanol—Nausea—Carmustine—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Butorphanol—Vomiting—Mitoxantrone—lymphatic system cancer	0.00161	0.00161	CcSEcCtD
Butorphanol—Rash—Mitoxantrone—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Butorphanol—Dermatitis—Mitoxantrone—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Butorphanol—Chills—Methotrexate—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Butorphanol—Headache—Mitoxantrone—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Butorphanol—Erythema—Methotrexate—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Butorphanol—Nausea—Vincristine—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Butorphanol—Nausea—Mitoxantrone—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Butorphanol—Back pain—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Butorphanol—Vision blurred—Methotrexate—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Butorphanol—Vertigo—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Butorphanol—Cough—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Butorphanol—Convulsion—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Butorphanol—Chest pain—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Butorphanol—Confusional state—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Butorphanol—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Butorphanol—Anorexia—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Butorphanol—Hypotension—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Butorphanol—Insomnia—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Butorphanol—Paraesthesia—Methotrexate—lymphatic system cancer	0.00114	0.00114	CcSEcCtD
Butorphanol—Dyspnoea—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Butorphanol—Somnolence—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Butorphanol—Decreased appetite—Methotrexate—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Butorphanol—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Butorphanol—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00103	0.00103	CcSEcCtD
Butorphanol—Urticaria—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Butorphanol—Abdominal pain—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Butorphanol—Body temperature increased—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Butorphanol—Asthenia—Methotrexate—lymphatic system cancer	0.000908	0.000908	CcSEcCtD
Butorphanol—Pruritus—Methotrexate—lymphatic system cancer	0.000895	0.000895	CcSEcCtD
Butorphanol—Dizziness—Methotrexate—lymphatic system cancer	0.000837	0.000837	CcSEcCtD
Butorphanol—Vomiting—Methotrexate—lymphatic system cancer	0.000804	0.000804	CcSEcCtD
Butorphanol—Rash—Methotrexate—lymphatic system cancer	0.000798	0.000798	CcSEcCtD
Butorphanol—Dermatitis—Methotrexate—lymphatic system cancer	0.000797	0.000797	CcSEcCtD
Butorphanol—Headache—Methotrexate—lymphatic system cancer	0.000793	0.000793	CcSEcCtD
Butorphanol—Nausea—Methotrexate—lymphatic system cancer	0.000751	0.000751	CcSEcCtD
